Company / Operating Margin
Decoy Therapeutics Inc. Operating Margin History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-696.3%
FY2022
5-year range
-3946.5% / -86.3%
FY2018-FY2022
Trend
-368.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -368% YoY in FY2022, a notable deviation from the 4-year average annual change of -102%.
Based on SEC 10-K filings.
-696.3% in FY2022 with a 3-year CAGR of -609.9%.
Declined from -238.5% to -696.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -609.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, operating margin decreased 368.0% year-over-year.
- Peak operating margin was recorded in FY2019.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -696.3% | -368.0% |
| FY2021 | -148.8% | +37.6% |
| FY2020 | -238.5% | -176.3% |
| FY2019 | -86.3% | +97.8% |
| FY2018 | -3946.5% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026